The American Journal of Geriatric Psychiatry publishes on the diagnosis and classification of psychiatric disorders of later life, epidemiological and biological correlates of mental health of older adults, and psychopharmacology and other somatic treatments.
As part of an open call for papers, Elsevier and the editors of The American Journal of Geriatric Psychiatry would like to make these select articles receiving the most online engagement available free through February 28, 2019:
Mental Health Integration in Geriatric Patient-Aligned Care Teams in the Department of Veterans Affairs
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in
Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month TrialPilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression
Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults
Cognition and Dopamine D Receptor Availability in the Striatum in Older Patients with Schizophrenia
Gay and Gray Session: An Interdisciplinary Approach to Transgender Aging
Hospital Elder Life Program: Systematic Review and Meta-analysis of Effectiveness
Refining Delirium: A Transtheoretical Model of Delirium Disorder with Preliminary Neurophysiologic Subtypes
Data Security and Privacy in Apps for Dementia: An Analysis of Existing Privacy Policies
Longitudinal Associations Between Cognitive Functioning and Depressive Symptoms
Among Older Adult Spouses in the Cardiovascular Health Study
医学
Journal of Biomedical Informatics
Call for papers: Deep phenotyping for Precision Medicine
We invite submissions for a special issue of the Journal of Biomedical Informatics focused on Deep Phenotyping to enable Precision Medicine. This special issue aims to provide a collection of emerging theories, cutting-edge methodologies, and novel technologies that enable scal- able human phenotype discovery and application in clinical data for continuous health learning.
An important goal of Precision Medicine is to develop a framework for creating a new taxonomy of human diseases based on molecular biology and then to create it [1]. Towards this goal, clinical data have been recognized as the basic staple of health learning [2]. The rapidly growing interoperable clinical datasets, including electronic health re- cords (EHR), patient-generated self-tracking data, administrative and claims records, and clinical research results data, have presented un- precedented opportunities for developing high-throughput methods for deep phenotyping.
In the context of this special issue, phenotype is “the trait or ob- servable characteristic of a human being representing his or her unique morphological, biochemical, physiological, or behavioral property” [3]. Related, phenotyping refers to the process of characterization or clas- sification of a patient’s phenotype. Deep phenotyping further empha- sizes the precision and comprehensiveness of the characterized phe- notype [4]. Fundamental to studying disease similarities to assist in the development of a precise disease taxonomy, deep phenotyping can shed light on gene functions and enable precise diagnoses, subtyping, and treatments. Software or algorithms leveraging deep phenotyping for gene prioritization have evolved to the point of demonstrating their usefulness in genomic diagnostic decision support [5–13].
Possible topics include, but are not limited to:
Computational phenotype analysis (e.g., causal [14] or probabilistic phenotyping [15])
Temporal phenotyping
High-throughput phenotyping
Deep learning for phenotyping
Next-generation phenotyping of electronic health records [16]
Population Physiology using electronic health records [17]
High-fidelity phenotyping [18]
Natural language processing for phenotyping using textual content[13]
Using novel data sources (e.g., patient self-reported data, case re- ports, social media, or clinical research data) for deep phenotyping
Multi-modality phenotyping combining data, text, videos, images, sound, etc.
Integrating multiple data or knowledge sources for phenotype knowledge engineering
Cross-species phenotype knowledge discovery and engineering
Human Phenotype Ontology enhancement or applications
Phenotype-driven disease taxonomy development
Phenotype-driven disease diagnoses or subtyping
Issues and methods for improving the portability of phenotyping methods
Standards-based representation, sharing, and reuse of phenotyping algorithms
Methods for engaging domain experts in high-throughput deep phenotyping
医学
Addictive Behaviors
Call for papers for Special Issue on Internet and Smartphone Use Disorders - A Growing Health Issue in Asia?
Worldwide, the detrimental effects of excessive Internet and Smartphone use are the subject of intense and controversial debates. Recent conceptualizations of Internet and Smartphone Use Disorders (IUD and SUD) take account of the growing concerns with respect to negative effects on mental health. Moreover, research on the addictive potential of digital media has steadily increased during the last decades. Following an initial case report published by Kimberly Young in 1996 describing a patient being “addicted” to the Internet, research started to surge in this field. Accumulating evidence from different lines of research meanwhile emphasizes potential detrimental effects of excessive and escalating Internet and Smartphone use on mental health, now often broadly summarized as Technology Related Use Disorders. Following the inclusion of Internet Gaming Disorder as emerging disorder in the DSM 5 and the very recent inclusion of (Online and Offline) Gaming Disorder as a specific form of IUD in the beta-draft of ICD-11, the present special issue calls for papers with cutting edge research examining potential detrimental effects of excessive technology use, including its addictive potential as well as more general detrimental effects on mental health from Asia. Research rooted in psychology, neuroscience, computational approaches and fields at the intersection such as neuroinformatics will be considered.
As the prevalence of Internet and Smartphone Use Disorders are particularly high in many Asian countries, the present call for papers will exclusively focus on works dealing with the topic in Asia. Of note, this means that all submissions will need to include empirical data from an Asian country in the mentioned research area. Moreover, cross-cultural works on IUD/SUD will also be considered, but only if empirical data from an Asian country will be included in the present work. Works targeting potential explanations for the higher prevalence of IUD/SUD in Asia as compared to other areas of the world would be a particularly good fit for the present special issue. Review research pieces may be submitted, however, please discuss the exact proposed topic with the editors, Profs Montag (christian.montag@uni-ulm.de) or Becker (ben_becker@gmx.de) prior to submission. All submissions will undergo rigorous peer-review before being accepted for publication.
In line with the terminology proposed in ICD-11 and earlier in DSM-5, we refrain from using the somewhat more classic term Internet addiction and ask authors to use Internet Use Disorder and Smartphone Use Disorder terminology. Aside from work dealing with “unspecified” IUD, characterizing persons overusing many different channels of the Internet and/or filling in questionnaires on generalized IUD, the present call for papers seeks submissions on use disorders in the context of online pornography, online buying, online gaming, online gambling and online communication (e.g. WeChat). Given the dramatic rise in smartphone users over the last eleven years since the inception of the iPhone and the worldwide discussion on the nature of excessive smartphone use, paper submissions on SUD are a good fit with the proposed special issue.
医学
Phytomedicine
From Plants to Pharmacy Shelf: Focus on Phytomedicine
In the recent years, phytotherapy field have witnessed a tremendous progress. Perhaps, among the most notable example from the recent years is the 2015 Nobel Prize in Physiology and Medicine, awarded to prof. Tu for the artemisinin’s discovery (Phytomedicine, 2015, 22: A1-A3). Nowadays, in excess of 25% of all medicines are derived either directly or indirectly from plants. Morphine and codeine (analgesic), paclitaxel (antineoplastic) and galanthamine (reversible cholinesterase inhibitor), besides artemisinin are good examples in this direction and amongst the best-selling drugs worldwide (Food and Chemical Toxicology, 2018, 122: 203-205). Recently in the USA, for instance, two drug applications have been approved for marketing botanical products as prescription drugs, namely Mytesi (formally known as Fulyzaq; crofelemer), an oral drug for the treatment of HIV-related diarrhea and Veregen (sinecatechins), a topical drug for the treatment of genital and perianal warts. These drug approvals are testimonial examples that complex botanical mixtures can be developed to meet the FDA standards of safety, efficacy and quality (FDA/CDER SBIA Chronicles, 2015).
The International Conference on Natural Products Utilization: from Plants to Pharmacy Shelf (ICNPU-2019)traditionally attempt to cover the wide spectrum of application of plants with special emphasis on the sustainable use of natural products, emerging -omics platforms and recent trends in (ethno)pharmacology, toxicology, molecular biology and biotechnology.
This Special issue of Phytomedicine (IF20173.61; Q1 in Complementary and Alternative Medicine) is designed to accommodate selected papers (reviews as well as original research articles) that fit to the Phytomedicine aims and scope (tentative authors can kindly consult here:www.elsevier.com/journals/phytomedicine/0944-7113/guide-for-authors). The ICNPU-2019 attendees are encouraged to propose an article on a subject relevant to the journal’s focus. Please, kindly send a synopsis and CV to the Guest Editor atmilengeorgiev@gbg.bg. The publication is by invitation only.
Invited authors have to submit their manuscripts online through the Elsevier Editorial System by selecting " ICNPU-2019" as the "Article Type" so that their papers are included in this special issue.
医学
Journal of the American Medical Directors Association
Call for Papers on Infection Prevention and Management in Long-Term Care
The Journal is partnering with theCDC Division of Healthcare Quality Promotionto publish a theme issue focusing onemerging issues in infection prevention and management in long-term care. The goal of this issue is to advance practice, policy, and research in areas including infection prevention; regulation; risk assessment; surveillance; antibiotic use, resistance patterns, and stewardship; staffing challenges; and others. All submissions must have relevance for practice and/or policy.
Article types included in this call for papers include original studies, review articles, special articles, controversies in care, pragmatic innovations, and editorials. For details on submission types, see https://www.jamda.com/content/authorinfo. Interested authors are encouraged to send a brief letter of inquiry (up to 300 words, specifying type of article and containing a draft abstract) to the managing editor atjamda@jjeditorial.combefore March 1, 2019.
The submission deadline for this issue is June 30, 2019.
Recent research published on this topic includes:
Infection Trends in US Nursing Home
Implementing a Pilot Trial of an Infection Control Program in Nursing Homes: Results of a Matched Cluster Randomized Tria
Template for an Antibiotic Stewardship Policy for Post-Acute and Long-Term Care Settings
Current Prescribing Practices for Skin and Soft Tissue Infections in Nursing Homes
In an increasingly mobile world, more children than ever before, from newborn babies to adolescents, travel and cross borders. Apart from children that travel for pleasure or to visit family, the pre- and post-travel care of special pediatric risk groups such as children of expatriates, adopted or breastfeeding children, unaccompanied minors, and children with special health care needs represent significant challenges to health care providers. This special issue will consider systematic reviews, original research, diagnostic challenges and correspondence that aim to add to the evidence base of pediatric travel medicine.
Papers submitted before August 2019 will have the best chance of being included in this online special issue.
This themed issue will address future directions in travel medicine. It will encompass topics such as new vaccines, vaccination schedules and travel health medications. Other focus areas will include novel travel trends and populations, innovative ways of communicating health advice in both pre- and during travel settings and the impact of climate change and global dynamics on the practice of travel medicine.
As a virtual special issue, papers will be added to this collection immediately after acceptance and they will be published in regular issues of the journal. All systematic reviews, original research, diagnostic challenges and correspondence on this topic, submitted by October 2019, will be considered for inclusion.
爱思唯尔提供信息分析解决方案和数字化工具,包括研究战略管理、研发绩效、临床决策支持、专业教育等。其前身可追溯自16世纪,而现代公司则起于1880年,爱思唯尔出版2500余种期刊,包括《柳叶刀》、《四面体》、《细胞》以及教科书《格雷氏解剖学》等。每年共有350,000篇论文发表在爱思唯尔公司出版的期刊中,以及全世界最大的摘要和引文数据库Scopus等。爱思唯尔(Elsevier)是医学与其他科学文献出版社之一,2016年中国高被引学者榜单的研究数据来自爱思唯尔旗下的Scopus数据库,共有来自社会科学、物理、化学、数学、经济等38个学科的1776名有世界影响力的中国学者入选。学术出版业巨头爱思唯尔(Elsevier)正式发布2017年中国高被引学者(Chinese Most Cited Researchers)榜单,本次国内共有1793位学者入选。